Title:
Budesonide: A promising candidate therapeutic for early COVID-19

dc.contributor.authorShailesh Kumar Patel
dc.contributor.authorRakesh Kumar
dc.contributor.authorJigyasa Rana
dc.contributor.authorAditya Agrawal
dc.contributor.authorAlok Singh
dc.contributor.authorAdesh Kumar
dc.date.accessioned2026-02-07T10:39:02Z
dc.date.issued2021
dc.description.abstract[No abstract available]
dc.identifier.doi10.1016/j.amsu.2021.102605
dc.identifier.issn20490801
dc.identifier.urihttps://doi.org/10.1016/j.amsu.2021.102605
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/37423
dc.publisherElsevier Ltd
dc.subjectBudesonide
dc.subjectClinical trial
dc.subjectCorticosteroid
dc.subjectCOVID-19
dc.subjectDrug
dc.subjectInhaled
dc.titleBudesonide: A promising candidate therapeutic for early COVID-19
dc.typePublication
dspace.entity.typeLetter

Files

Collections